SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

JADUE T, Andrés; GONZALEZ L, Roberto  y  IRARRAZABAL LL, Manuel J. Cirugía de revascularización miocárdica versus angioplastía coronaria con stent en enfermedad de tres vasos y/o tronco común izquierdo en diabéticos: meta-análisis de estudios aleatorios. Rev. méd. Chile [online]. 2012, vol.140, n.5, pp.640-648. ISSN 0034-9887.

    1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-9. [ Links ]

    2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52. [ Links ]

    3. Lüscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 2003; 108: 1655-61. [ Links ]

    4. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA 2005; 293: 1501-8. [ Links ]

    5. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110: e340-e437. [ Links ]

    6. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2010; 38: S1-S52. [ Links ]

    7. The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000; 35: 1122-9. [ Links ]

    8. Babapulle MN, Joseph L, Bélisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364: 583-91. [ Links ]

    9. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-900. [ Links ]

    10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. [ Links ]

    11. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001; 104: 533-8. [ Links ]

    12. Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel eluting stents. J Am Coll Cardiol 2010; 55: 1067-75. [ Links ]

    13. Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Bel der M, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 2010; 55: 432-40. [ Links ]

    14. Elsässer A, Möllmann H, Nef HM, Hamm CW. How to revascularize patients with diabetes mellitus: bypass or stents and drugs? Clin Res Cardiol 2006; 95: 195-203. [ Links ]

    15. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001; 24: 1936-40. [ Links ]

    16. Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527-32. [ Links ]

    17. Lee MS, Yang T, Dhoot J, Iqbal Z, Liao H. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease. Am J Cardiol 2010; 105: 1540-4. [ Links ]

    18. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009 5; 360: 961-72. [ Links ]

    19. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006; 151: 1194-204. [ Links ]

    20. Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R, et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 1999; 117: 855-72. [ Links ]

    21. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Ståhle E, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 32: 2125-34. [ Links ]

    22. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 2003 16; 41: 1293-304. [ Links ]

    23. Cohen DJ, Van Hout B, Serruys PW, Mohr FW, Macaya C, den Heijer P, et al. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med 2011; 364: 1016-26. [ Links ]

    24. Brown ML, Gersh BJ, Holmes DR, Bailey KR, Sundt TM 3rd. From randomized trials to registry studies: translating data into clinical information. Nat Clin Pract Cardiovasc Med 2008; 5: 613-20. [ Links ]

    25. Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv 2008; 1: 211-7. [ Links ]

    26. Guyton RA. Coronary artery bypass is superior to drugeluting stents in multivessel coronary artery disease. Ann Thorac Surg 2006; 81: 1949-57. [ Links ]

    27. Irarrázaval MJ. ¿Es relevante el estudio SYNTAX para la toma de decisiones en cardiología? Rev Med Chile 2009; 37: 1535-7. [ Links ]

    28. Mohr F, Serryus P. The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study. One Year Results of the PCI and CABG Registries (en línea) (fecha de acceso 27 de octubre de 2011). URL disponible en: [ Links ]

    29. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352: 2174-83. [ Links ]

    30. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR. Drug-eluting stents vs coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358: 331-41. [ Links ]

    31. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J 2008; 155: 215-23. [ Links ]

    32. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002; 360: 965-70. [ Links ]

    33. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 1082-9. [ Links ]

    34. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski N, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008; 51: 538-45. [ Links ]

    35. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol 2010; 56: S1-42. [ Links ]

    36. Reichenspurner H, Conradi L, Cremer J, Mohr FW. Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated. Clin Res Cardiol 2010; 99: 541-4. [ Links ]